Showing results (101-110 of 123) with videos related to
Sort By:
Pageof 13
Blood Advances|July 21, 2019
Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantationMax Jan, Matthew J Leventhal, Elizabeth A Morgan, et al.Blood|June 2, 2020
A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantationMatthew S Davids, Haesook T Kim, Caitlin Costello, et al.Haematologica|August 5, 2018
Upper gastrointestinal acute graft-<i>versus</i>-host disease adds minimal prognostic value in isolation or with other graft-<i>versus</i>-host disease symptoms as currently diagnosed and treatedSarah Nikiforow, Tao Wang, Michael Hemmer, et al.Blood Advances|October 6, 2021
Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and activeJacqueline S Garcia, Haesook T Kim, H Moses Murdock, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 5, 2024
Allogeneic B cell immunomodulatory therapy in amyotrophic lateral sclerosisRuxandra F Sîrbulescu, Katharine Nicholson, Kento Kawai, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2020
Axicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and ToxicityCaron A Jacobson, Bradley D Hunter, Robert Redd, et al.Journal of Hematology & Oncology|February 13, 2025
First-in-human evaluation of memory-like NK cells with an IL-15 super-agonist and CTLA-4 blockade in advanced head and neck cancerRoman M Shapiro, Michal Sheffer, Matthew A Booker, et al.BMJ Oncology|April 1, 2026
BASECAMP-1 screening study: a model for efficient enrolment in precision oncology clinical trialsJ Randolph Hecht, Julian R Molina, Kirstin Liechty, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2017
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for LymphomaChristopher J Gibson, R Coleman Lindsley, Vatche Tchekmedyian, et al.Nature Communications|February 6, 2024
A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndromeTerese C Hammond, Marco A Purbhoo, Sapana Kadel, et al.Pageof 13